To further elucidate whether SNF2L modulates the sensitivity of cancer cells to APR-246 through SLC7A11, we ectopically expressed SLC7A11 in SNF2L-deficient MDA-MB-231 cells (Fig. 5A, uncropped original western blots Fig. 5A). This evidence concerns the gene SMARCA1 and cancer.